Polyethylene Glycol

Osmotic Laxative Polyethylene Glycol (PEG) Electrolyte Solutions

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 1-2 g/kg (as PEG 3350) or 10-20 mL/kg of a 10% solution Once daily or divided into two doses Duration: 1-3 days for constipation; single dose for bowel evacuation
Notes: For bowel cleansing, administer a total of 25-40 mL/kg of a balanced electrolyte solution over 2-4 hours. Ensure adequate hydration.
Cat PO 1-2 g/kg (as PEG 3350) or 10-20 mL/kg of a 10% solution Once daily or divided into two doses Duration: 1-3 days for constipation; single dose for bowel evacuation
Notes: For megacolon, long-term use may be needed. Monitor hydration and electrolyte balance.
Horse PO (via nasogastric tube) 1-2 g/kg (as PEG 3350) or 10-20 mL/kg of a 10% solution Once daily Duration: 1-2 days
Notes: Administer via nasogastric tube. Ensure adequate hydration. Use with caution in cases of suspected intestinal obstruction.
Cattle PO 1-2 g/kg (as PEG 3350) Once daily Duration: 1-2 days
Notes: Not commonly used; may be used in calves with constipation. Ensure adequate hydration.
Small Ruminants PO 1-2 g/kg (as PEG 3350) Once daily Duration: 1-2 days
Notes: Not commonly used; use with caution and under veterinary supervision.
Rabbit PO 1-2 g/kg (as PEG 3350) Once daily Duration: 1-2 days
Notes: Use only under veterinary guidance for gastrointestinal stasis. Ensure adequate hydration.

Clinical Indications & Species Uses

General Indications
  • Osmotic laxative for constipation and bowel cleansing
Dog (Canine)
  • Constipation
  • Fecal impaction
  • Bowel evacuation before colonoscopy or surgery
  • Megacolon (adjunctive therapy)
Cat (Feline)
  • Constipation
  • Fecal impaction
  • Megacolon (adjunctive therapy)
  • Bowel evacuation before diagnostic procedures
Horse (Equine)
  • Impaction colic
  • Constipation
  • Bowel evacuation before surgery or diagnostic imaging
Cattle (Bovine)
  • Occasionally used for constipation in calves
Rabbit & Small Mammals
  • May be used for gastrointestinal stasis under veterinary guidance

Pharmacology & Mechanism of Action

Drug Class: Osmotic Laxative | Pharmacological Group: Polyethylene Glycol (PEG) Electrolyte Solutions

Mechanism of Action: Polyethylene glycol (PEG) is a non-absorbable, osmotically active polymer that acts as an osmotic laxative. When administered orally, PEG retains water in the gastrointestinal lumen through osmotic forces, increasing intraluminal fluid volume. This distension stimulates peristalsis and promotes the passage of stool. PEG is not metabolized in the gut and is excreted unchanged in feces. In veterinary medicine, PEG is often used for bowel evacuation before diagnostic procedures or surgery, and for the management of constipation and fecal impaction.

Pharmacodynamics: PEG produces a laxative effect by increasing the water content and volume of the intestinal contents, which softens stool and stimulates colonic motility. The onset of action is typically 1-2 hours after administration, with peak effect occurring within 2-6 hours. The effect is dose-dependent and can be titrated to achieve the desired level of bowel cleansing. PEG does not cause significant electrolyte shifts when used as an isotonic solution, making it safer than some other osmotic laxatives.

⚑ Pharmacokinetics Summary

Absorption: PEG is minimally absorbed from the gastrointestinal tract. The small fraction that is absorbed is excreted unchanged in the urine. The majority (approximately 95-98%) is eliminated in the feces.
Distribution: PEG is confined primarily to the gastrointestinal lumen. The small absorbed fraction distributes into extracellular fluid and is not significantly bound to tissues.
Metabolism: PEG is not metabolized in the body. It is resistant to bacterial degradation in the gut.
Excretion: PEG is excreted unchanged in the feces. The small absorbed fraction is excreted unchanged in the urine via glomerular filtration.
Half-Life: The half-life of PEG in the systemic circulation is approximately 1-2 hours, but since it is minimally absorbed, the effective half-life in the gut is not clinically relevant.
Bioavailability: Oral bioavailability is negligible (<1%) due to minimal absorption.
Protein Binding: PEG does not bind to plasma proteins.

Available Formulations & Strengths

Oral Powder (for solution) PEG 3350 powder (e.g., 17 g per dose, 255 g bottle) (PO)
Oral Solution (pre-mixed) Various concentrations (e.g., 10% solution) (PO)
Electrolyte Lavage Solution PEG 3350 with electrolytes (e.g., 236 g per 4 L) (PO)

Contraindications & Clinical Warnings

Contraindications:
  • Gastrointestinal obstruction or perforation
  • Ileus or gastric retention
  • Known hypersensitivity to polyethylene glycol
  • Severe dehydration or electrolyte imbalances (unless corrected first)
  • Renal failure (use with caution)
Warnings & Clinical Precautions:
  • Use with caution in patients with compromised renal or cardiac function
  • Ensure adequate hydration during therapy
  • Monitor electrolyte balance, especially with prolonged use
  • Do not use in animals with suspected intestinal obstruction
  • Use with caution in debilitated or geriatric animals
  • In horses, administer via nasogastric tube only; avoid aspiration
  • For food animals, observe withdrawal times

Adverse Effects & Reactions

Common:

  • Vomiting
  • Nausea
  • Abdominal cramping
  • Diarrhea
  • Flatulence

Serious / Severe:

  • Aspiration pneumonia (if aspirated)
  • Electrolyte imbalances (with excessive use)
  • Dehydration
  • Colic in horses

Rare:

  • Allergic reactions
  • Mallory-Weiss tear (in humans; rare in animals)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Oral medications PEG may reduce the absorption of orally administered drugs; separate administration by at least 2 hours. Moderate
Diuretics Increased risk of electrolyte imbalances. Moderate
NSAIDs Potential for increased gastrointestinal irritation. Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Severe diarrhea
  • Dehydration
  • Electrolyte imbalances
  • Lethargy
  • Weakness

Emergency Treatment Protocol: Discontinue PEG administration. Provide supportive care including intravenous fluids to correct dehydration and electrolyte imbalances. Monitor serum electrolytes and renal function. In severe cases, hospitalization may be required.

Food Animal Withdrawal Times

πŸ₯© Meat: 0 daysπŸ₯› Milk: 0 daysπŸ₯š Eggs: 0 days

PEG is not absorbed and is considered safe for food animals; however, consult regulatory guidelines for specific products. No withdrawal times are typically required.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (20-25Β°C) in a dry place.

Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Once reconstituted, solutions should be refrigerated and used within 24-48 hours.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: PEG is FDA-approved for human use as an osmotic laxative (e.g., MiraLax). Not specifically approved for veterinary use, but may be used off-label.

Extra-Label (Off-Label) Use: PEG is not FDA-approved for veterinary use in most species; use is considered extra-label. In the US, extra-label use in food animals requires a valid veterinary-client-patient relationship and must comply with AMDUCA regulations. Withdrawal times may need to be extended if used extra-label.

Clinical Pearls & Practice Notes

πŸ’‘ Clinical Insights: Polyethylene glycol is a safe and effective osmotic laxative for managing constipation and bowel cleansing in veterinary patients. It is particularly useful in cats with megacolon and dogs with constipation. For bowel cleansing, use a balanced electrolyte solution to prevent electrolyte disturbances. Always ensure adequate hydration. In horses, use with caution and only via nasogastric tube. For food animals, observe appropriate withdrawal times if required. Monitor for adverse effects, especially in debilitated patients.

References & Literature

  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Papich Veterinary Pharmacology and Therapeutics
  • πŸ“š Compendium of Veterinary Products (CVP)